Co-Authors
This is a "connection" page, showing publications co-authored by Tianlei Ying and Dimiter Dimitrov.
Connection Strength
2.208
-
Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus. J Infect Dis. 2016 Mar 15; 213(6):877-9.
Score: 0.632
-
Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol. 2014 Jul; 88(14):7796-805.
Score: 0.580
-
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV. Antibodies (Basel). 2019 Nov 04; 8(4).
Score: 0.213
-
Human monoclonal antibodies as candidate therapeutics against emerging viruses. Front Med. 2017 Dec; 11(4):462-470.
Score: 0.186
-
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody. Nat Commun. 2015 Sep 15; 6:8223.
Score: 0.160
-
No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses. Proc Natl Acad Sci U S A. 2015 Sep 15; 112(37):E5115.
Score: 0.159
-
Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections. Microbes Infect. 2015 Feb; 17(2):142-8.
Score: 0.151
-
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets. Antiviral Res. 2017 07; 143:30-37.
Score: 0.044
-
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection. Sci Rep. 2016 08 19; 6:31629.
Score: 0.043
-
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection. J Infect Dis. 2016 May 15; 213(10):1557-61.
Score: 0.041